Xiangyang Liu
NHC Key Laboratory Of Hormones And Development And Tianjin Key Laboratory Of Metabolic Diseases
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Druggable Mendelian randomization prioritizes CDH2 and supports finerenone as a candidate therapeutic strategy for diabetic retinopathy.
Journal: Frontiers in pharmacology
Published: April 25, 2026
The association between physical activity and cardiovascular events, tumors and all-cause mortality in patients with maintenance hemodialysis with different nutritional status.
Journal: Scientific reports
Published: February 04, 2024
The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian randomization study.
Journal: Frontiers in endocrinology
Published: September 04, 2023
Integrin β6 mediates epithelial-mesenchymal transition in diabetic kidney disease.
Journal: Molecular and cellular endocrinology
Published: February 17, 2023
Sex-specific effect of perfluoroalkyl substances exposure on liver and thyroid function biomarkers: A mixture approach.
Journal: International journal of hygiene and environmental health
Published: December 21, 2022
Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway.
Journal: Frontiers in physiology
Published: November 18, 2021
Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes.
Journal: Frontiers in physiology
Published: July 21, 2021
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro.
Journal: Frontiers in pharmacology
Published: October 27, 2020
An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells.
Journal: Cancer letters
Published: June 20, 2020
Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
Journal: Metabolism: clinical and experimental
Published: April 19, 2020
Urinary miR-3137 and miR-4270 as potential biomarkers for diabetic kidney disease.
Journal: Journal of clinical laboratory analysis
Published: February 12, 2020
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Journal: Clinical science (London, England : 1979)
Published: June 03, 2019
Last Updated: 09/26/2026